Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-26-028571
Filing Date
2026-04-30
Accepted
2026-04-30 06:59:07
Documents
18
Period of Report
2026-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A rmti-20260428.htm   iXBRL DEF 14A 611837
3 rmti-20260428_g1.jpg GRAPHIC 1691
4 rmti-20260428_g2.jpg GRAPHIC 40638
5 rmti-20260428_g3.jpg GRAPHIC 296789
6 rmti-20260428_g4.jpg GRAPHIC 298997
7 rmti-20260428_g5.jpg GRAPHIC 508957
8 rmti-20260428_g6.jpg GRAPHIC 258770
  Complete submission text file 0001628280-26-028571.txt   4322498

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rmti-20260428.xsd EX-101.SCH 922
21 EXTRACTED XBRL INSTANCE DOCUMENT rmti-20260428_htm.xml XML 64230
Mailing Address 30142 WIXOM ROAD WIXOM MI 48393
Business Address 30142 WIXOM ROAD WIXOM MI 48393 8004493353
ROCKWELL MEDICAL, INC. (Filer) CIK: 0001041024 (see all company filings)

EIN.: 383317208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23661 | Film No.: 26919963
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)